The influence of sex steroid hormones on periodontium can be knockdown with good plaque control. The aim of the present study was to evaluate periodontal status in pre-and postmenopausal women with periodontitis following non-surgical therapy. Methods: Total 60 female patients' periodontal status was measured by periodontal index (PRI), and oral hygiene status was measured by plaque index (PI). Both the parameters were measured at baseline i.e. before scaling and root planing and after 3 months intervals post treatment. Data were analyzed using SPSS version 21. Results: The mean PRI scores in premenopausal group were 5.68 ± 0.64 and 2.53 ± 0.13, and PI scores were 1.84 ± 0.17 and 0.91 ± 0.13 respectively at baseline and 3 months. The mean PRI scores in postmenopausal group were 6.08 ± 0.46 and 2.55 ± 0.12, and PI scores were 1.86 ± 0.24 and 1.00 ± 0.24 respectively at baseline and 3 months. Conclusions: There was more desirable response to non-surgical periodontal therapy in both the groups but not significant variation in between two groups. 
Introduction
Endocrine system being a complex homeostasis plays an important representation in promoting periodontitis (PD), which is characterized by inflammation of the supporting tissues of the teeth, including the gingiva, alveolar bone, and periodontal ligament. PD is a chronic inflammatory process that occurs in response to a predominantly gramnegative bacterial infection originating in dental plaque. 1 PD leads to progressive and irreversible loss of bone and periodontal ligament attachment, as inflammation extends from the gingiva into adjacent bone and ligament. Signs and symptoms of progressing PD include red, swollen gums that may appear to have pulled away from the teeth, persistent bad breath, pus between the teeth and gums, and loose or separating teeth. 2 Menopause archetypically occurs in the fifth decade of life in women. 3 Menopause in women is a physiological state that gives rise to adaptive changes at both the systemic and oral level. Menopause literally means "without estrogen" and by definition, it is the time at which cyclic ovarian function, as manifested by menstruation ceases. 4 The oral alterations noted at menopause are frequently related to hormonal changes although a physiological aging of the oral tissues also plays a contributing role. 5 Gingival epithelium becomes thinner and more prone to inflammatory changes during menopause. 6 On the other hand salivary flow rate and composition may be altered and contribute to the development of several oral conditions. 7 Sudden decreases in estrogen production during menopause stage contemplate to be the main cause of primary osteoporosis, which also affects jawbones. 8 It has been suggested that this reduction in bone mineral density could contribute to periodontal disease progression. 9 In conjunction with effect on bone, estrogens also interfere with other periodontal tissues (gingiva and periodontal ligament) and influence host immune-inflammatory responses. 10 In this study among pre-and postmenopause, which one is reciprocating to periodontal treatment was scrutinized. 
Materials and Methods

Study population
Statistical analysis
Statistical analysis was done by using IBM SPSS version 21 software (SPSS Inc., Chicago, IL, USA). Intergroup comparison and percentage decrement was done by using independent sample t-test and intra group comparison was done by paired t-test. All P-values of less than 0.05 were considered to indicate statistical significance.
Results
There was statistically significant reduction in the mean values of all the parameters from baseline to 3 months within the group I. The mean PRI levels have reduced from 5.68 ± 0.64 at baseline to 2.53 ± 0.13 at 3 months after treatment. The mean PI levels have reduced from 1.84 ± 0.17 at baseline to 0.91 ± 0.13 at 3 months after treatment.
There is statistical significant difference between baseline and 3 months post treatment for all the parameters (P < There was also a statistically significant reduction in the mean values of all the parameters from baseline to 3 months within group II. The mean PRI levels have reduced from 6.08 ± 0.46 at baseline to 2.55 ± 0.12 at 3 months after treatment. The mean PI levels have reduced from 1.86 ± 0.24 at baseline to 1.00 ± 0.24 at 3 months after treatment. There is statistical significant difference between baseline and 3 months post treatment for all the parameters (P < 0.001) ( Table 2 ).
The inter group comparison of these values from baseline to 3 months has shown no significant difference (Table 3 , triggers a wide range of changes in women' s body, and the oral cavity is also not an exceptional. 13 Estrogen deficiency, which affects systemically the sequence of bone resorption and formation, has received an increasing attention in relation to the stability of alveolar bone structure in postmenopausal women. 14 Found wanting of estrogen in menopause, the anti-inflammatory effect of this hormone on the periodontium and its supporting structures get compromised.
Another sex hormone which also plays an important role in bone metabolism during pre-and postmenopause is progesterone.
Repercussion of estrogen and progesterone function is different on different organ systems. Estrogen can influence the cytodifferentiation of stratified squamous epithelium, synthesis and maintenance of fibrous collagen. Additionally, estrogen receptors in osteoblast-like cells and receptors in periosteal fibroblasts provide a mechanism for direct action on bone as well as periodontal tissues. 15 Together affect the micro circulatory system by producing the following changes: swelling of endothelial cells and periocytes and responses, including antigen expression and presentation, and cytokine production, as well as the expression of apoptotic factors, and cell death. 24 Several studies have focused on the observation that immune system components have been identified as possessing sex steroid receptors. 16 Progesterone in particular has been shown to stimulate the production of the inflammatory mediator, prostaglandin E2 and to enhance the accumulation of polymorphonuclear leukocytes in the gingival sulcus. 25 In addition, sex steroid hormones seem to modulate the production of cytokines, 26 and progesterone has been shown to down regulate interleukin-6 (IL-6) production by human gingival fibroblasts to 50% of that of control values. 27 The steroid metabolites may also contribute to nutritional requirements of the pathogens, or enable synthesis of matrices associated with host evasion mechanisms. 28 Culture supernatants of these micro-organisms have been shown to enhance the expression of 5α -reductase activity in human gingiva and in cultured gingival fibroblasts, resulting in the formation of 5α -dihydrotestosterone (DHT) from androgen substrate. 29 The DHT can influence protein synthetic activity in these pathogens, for which there is a variety of ap- J MM
